-
1
-
-
0019966973
-
Impotence following radical prostatectomy: Insight into etiology and prevention
-
Walsh, P. C. and Donker, P. J.: Impotence following radical prostatectomy: insight into etiology and prevention. J Urol, 128: 492, 1982
-
(1982)
J Urol
, vol.128
, pp. 492
-
-
Walsh, P.C.1
Donker, P.J.2
-
2
-
-
0032883704
-
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
-
Catalona, W. J., Carvalhal, G. F., Mager, D. E. and Smith, D. S.: Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol, 162: 433, 1999
-
(1999)
J Urol
, vol.162
, pp. 433
-
-
Catalona, W.J.1
Carvalhal, G.F.2
Mager, D.E.3
Smith, D.S.4
-
3
-
-
0034817278
-
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
-
Han, M., Partin, A. W., Pound, C. R., Epstein, J. I. and Walsh, P. C.: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am, 28: 555, 2001
-
(2001)
Urol Clin North Am
, vol.28
, pp. 555
-
-
Han, M.1
Partin, A.W.2
Pound, C.R.3
Epstein, J.I.4
Walsh, P.C.5
-
4
-
-
0003602054
-
-
SEER Program, National Cancer Institute. Bethesda: National Cancer Institute, pub# 99-4543
-
Stanford, J. L., Stephenson, R. A., Coyle, L. M., Cerhan, J., Correa, R., Eley, J. W. et al: Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute. Bethesda: National Cancer Institute, pub# 99-4543, 1999
-
(1999)
Prostate Cancer Trends 1973-1995
-
-
Stanford, J.L.1
Stephenson, R.A.2
Coyle, L.M.3
Cerhan, J.4
Correa, R.5
Eley, J.W.6
-
5
-
-
0032820899
-
Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results
-
Catalona, W. J. and Smith, D. S.: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol, 160: 2428, 1998
-
(1998)
J Urol
, vol.160
, pp. 2428
-
-
Catalona, W.J.1
Smith, D.S.2
-
6
-
-
0028125318
-
5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
-
Catalona, W. J. and Smith, D. S.: 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol, 152: 1837, 1994
-
(1994)
J Urol
, vol.152
, pp. 1837
-
-
Catalona, W.J.1
Smith, D.S.2
-
7
-
-
0003527023
-
-
Philadelphia: J. B. Lippincott Co.
-
Beahrs, O. H., Henson, D. E., Hutter, R. V. P. and Kennedy, B. J.: American Joint Committee on Cancer: Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott Co., pp. 181-186, 1992
-
(1992)
American Joint Committee on Cancer: Manual for Staging of Cancer, 4th Ed.
, pp. 181-186
-
-
Beahrs, O.H.1
Henson, D.E.2
Hutter, R.V.P.3
Kennedy, B.J.4
-
8
-
-
0015950349
-
Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
-
Gleason, D. F., Mellinger, G. T. and the Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111: 58, 1974
-
(1974)
J Urol
, vol.111
, pp. 58
-
-
Gleason, D.F.1
Mellinger, G.T.2
-
9
-
-
0028138626
-
The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy
-
Trapasso, J. G., deKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol, 152: 1821, 1994
-
(1994)
J Urol
, vol.152
, pp. 1821
-
-
Trapasso, J.G.1
DeKernion, J.B.2
Smith, R.B.3
Dorey, F.4
-
10
-
-
0027997867
-
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer
-
Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P. and Barrett, D. M.: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol, 152: 1850, 1994
-
(1994)
J Urol
, vol.152
, pp. 1850
-
-
Zincke, H.1
Oesterling, J.E.2
Blute, M.L.3
Bergstralh, E.J.4
Myers, R.P.5
Barrett, D.M.6
-
11
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D. and Walsh, P. C.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
-
(1999)
JAMA
, vol.281
, pp. 1591
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
12
-
-
0034940986
-
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer
-
Han, M., Partin, A. W., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol, 166: 416, 2001
-
(2001)
J Urol
, vol.166
, pp. 416
-
-
Han, M.1
Partin, A.W.2
Piantadosi, S.3
Epstein, J.I.4
Walsh, P.C.5
-
13
-
-
0036141891
-
Cancer control with radical prostatectomy alone in 1,000 consecutive patients
-
Hull, G. W., Rabbani, F., Abbas, F., Wheeler, T. M., Kattan, M. W. and Scardino, P. T.: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol, 167: 528, 2002
-
(2002)
J Urol
, vol.167
, pp. 528
-
-
Hull, G.W.1
Rabbani, F.2
Abbas, F.3
Wheeler, T.M.4
Kattan, M.W.5
Scardino, P.T.6
-
14
-
-
0023778197
-
Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy
-
Catalona, W. J., Miller, D. R. and Kavoussi, L. R.: Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol, 140: 540, 1988
-
(1988)
J Urol
, vol.140
, pp. 540
-
-
Catalona, W.J.1
Miller, D.R.2
Kavoussi, L.R.3
|